Screening of Danish traffic cases for synthetic cannabinoids in whole blood by LC-MS/MS

Open access

ABSTRACT

A target screening method for the detection of 13 synthetic cannabinoids in whole blood was developed and validated. Samples underwent automated solid-phase extraction, and sample extracts were analyzed by liquid chromatography-positive electrospray ionization-tandem mass spectrometry using two transitions in multiple reaction monitoring mode. The limit of detection was between 0.1-2.5 ng/mL for the compounds except HU-210, and extraction recovery ranged from 59 to 78%. The method was used to screen 393 Danish traffic cases from 2012, where the driver was suspected of driving under the influence of drugs. No synthetic cannabinoids were identified in these samples. Additionally, the method was applied to a clinical intoxication case, and the synthetic cannabinoid AM- 2201 was identified in serum. We conclude that the prevalence of driving under the influence of synthetic cannabinoids in Denmark is likely to be low, and that synthetic cannabinoids are most likely to be encountered in the clinical setting.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] Pertwee R.G. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond Addict. Biol. 2008 13 147-159

  • [2] Auwarter V. Dresen S. Weinmann W. Muller M. Putz M. Ferreiros N. ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 2009 44 832-837

  • [3] Uchiyama N. Kikura-Hanajiri R. Kawahara N. Haishima Y. Goda Y. Identification of a cannabinoid analog as a new type of designer drug in a herbal product Chem. Pharm. Bull. (Tokyo) 2009 57 439-441

  • [4] Dresen S. Ferreiros N. Putz M. Westphal F. Zimmermann R. Auwarter V. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds J. Mass Spectrom. 2010 45 1186-1194

  • [5] Shanks K.G. Dahn T. Behonick G. Terrell A. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry J. Anal. Toxicol. 2012 36 360-371

  • [6] Uchiyama N. Kawamura M. Kikura-Hanajiri R. Goda Y. URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products Forensic Sci. Int. 2013 227 21-32

  • [7] European Monitoring Centre for Drugs and Drug Addiction European Drug Report 2013: Trends and Developments. 2013 http://www.emcdda.europa.eu/publications/edr/trends-developments/2013

  • [8] Kacinko S.L. Xu A. Homan J.W. McMullin M.M. Warrington D.M. Logan B.K. Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018 JWH-073 JWH-019 and JWH-250 in human whole blood J. Anal. Toxicol. 2011 35 386-393

  • [9] Shanks K.G. Dahn T. Terrell A.R. Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework J. Anal. Toxicol. 2012 36 145-152

  • [10] Dresen S. Kneisel S. Weinmann W. Zimmermann R. Auwarter V. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples J. Mass Spectrom. 2011 46 163-171

  • [11] Strano-Rossi S. Anzillotti L. Castrignano E. Romolo F.S. Chiarotti M. Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs “spice” and stimulants in oral fluid J. Chromatogr. A 2012 1258 37-42

  • [12] Kneisel S. Auwarter V. Kempf J. Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry Drug Test. Anal. 20135657-69 DOI: 10.1002/dta 1429

  • [13] Moran C.L. Le V.H. Chimalakonda K.C. Smedley A.L. Lackey F.D. Owen S.N.et al. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine Anal. Chem. 2011 83 4228-4236

  • [14] Hutter M. Broecker S. Kneisel S. Auwarter V. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ‘herbal mixtures’ using LC-MS/MS techniques J. Mass Spectrom. 2012 47 54-65

  • [15] Wohlfarth A. Scheidweiler K.B. Chen X. Liu H.F. Huestis M.A. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search Anal. Chem. 2013 85 3730-3738

  • [16] Teske J. Weller J.P. Fieguth A. Rothamel T. Schulz Y. Troger H.D. Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010 878 2659-2663

  • [17] Chimalakonda K.C. Seely K.A. Bratton S.M. Brents L.K. Moran C.L. Endres G.W.et al. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands Drug Metab Dispos. 2012 40 2174-2184

  • [18] Sobolevsky T. Prasolov I. Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine Forensic Sci. Int. 2010 200 141-147

  • [19] Sobolevsky T. Prasolov I. Rodchenkov G. Detection of urinary metabolites of AM-2201 and UR-144 two novel synthetic cannabinoids Drug Test. Anal. 2012 DOI: 10.1002/dta. 1418

  • [20] Musshoff F. Madea B. Kernbach-Wighton G. Bicker W. Kneisel S. Hutter M.et al. Driving under the influence of synthetic cannabinoids (“Spice”): a case series Int. J. Legal Med. 2013 DOI: 10.1007/s00414-013-0864-1

  • [21] Hermanns-Clausen M. Kneisel S. Szabo B. Auwarter V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings Addiction 2013 108 534-544

  • [22] Gunderson E.W. Haughey H.M. Ait-Daoud N. Joshi A.S. Hart C.L. “Spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans Am. J. Addict. 2012 21 320-326

  • [23] Bekendtgørelse om ændring af bekendtgørelse om klassificering af færdselssikkerhedsfarlige stoffer bilag 1 https://www.retsinformation.dk/Forms/R0710.aspx?id=138271#B1

  • [24] Andersen D. Rasmussen B. Linnet K. Validation of a fully automated robotic setup for preparation of whole blood samples for LC-MS toxicology analysis J. Anal. Toxicol. 2012 36 280-287

  • [25] Rivier L. Criteria for the identification of compounds by liquid chromatography-mass spectrometry and liquid chromatography-multiple mass spectrometry in forensic toxicology and doping analysis Analytica Chimica Acta 2003 492 69-82

  • [26] Ginsburg B.C. McMahon L.R. Sanchez J.J. Javors M.A. Purity of synthetic cannabinoids sold online for recreational use J. Anal. Toxicol. 2012 36 66-68

  • [27] Pedersen A.J. Dalsgaard P.W. Rode A.J. Rasmussen B.S. Muller I.B. Johansen S.S.et al. Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition J. Sep. Sci. 2013 36 2081-2089 DOI: 10.1002/jssc.201200921

  • [28] Sundhedsstyrelsen Illegale stoffer i Danmark Årsrapport 2012. 2013

  • [29] Lovett D.P. Yanes E.G. Herbelin T.W. Knoerzer T.A. Levisky J.A. Structure elucidation and identification of a common metabolite for naphthoylindole-based synthetic cannabinoids using LC-TOF and comparison to a synthetic reference standard Forensic Sci. Int. 2013 226 81-87

Search
Journal information
Cited By
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 256 116 2
PDF Downloads 131 72 0